Modular Lipoxin B4 Synthesis for Scalable, Fully Characterized Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing syntheses of lipoxin B4 (LXB4) are low yielding, have long synthetic routes, and lack full spectral characterization, hindering the study of its therapeutic potential in neurodegeneration and the identification of its biological targets.
Innovation Solution
A modular and scalable synthetic process for producing LXB4, involving reactions to form compounds of Formula I and Formula I′, including deprotection and selective semi-hydrogenation, with comprehensive structural characterization using 1D and 2D NMR, high resolution mass spectrometry, and optical rotation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If previous total syntheses of LXB4 are used, then the compound can be produced, but the synthetic routes are long and yields are low
Solution Approach 1:
The synthesis is divided into modular steps with distinct functional transformations. The route segments include: (1) formation of the conjugated tetraene system via selective semi-hydrogenation, (2) installation of hydroxyl groups at specific positions, (3) configuration control at stereocenters, and (4) final purification. This segmentation allows for optimized each step independently, improving overall yield and reducing time compared to linear sequential syntheses.
Solution Approach 2:
The patent employs parameter changes in the form of controlled hydrogenation conditions and selective reduction methods to achieve the desired tetraene configuration. By adjusting reaction parameters such as catalyst selection, hydrogen pressure, and temperature control, the synthesis achieves high yields with fewer steps, directly addressing the productivity and time loss contradictions.
2Measurement precision
If previous syntheses are used, then LXB4 can be produced, but full spectral characterization is lacking
Solution Approach 1:
The synthesis protocol incorporates multiple spectroscopic techniques (1D and 2D NMR, mass spectrometry, optical rotation) at key stages to provide feedback on structure and purity. This feedback mechanism ensures complete spectral characterization by comparing observed data with expected values, allowing for immediate correction of any deviations and ensuring high measurement precision without excessive complexity.
3Quantity of substance
If large quantities of LXB4 are synthesized, then therapeutic potential can be studied, but previous methods are low yielding
Solution Approach 1:
The synthesis protocol is designed for continuous operation with minimal isolation steps between reactions. The modular approach allows for continuous processing where intermediates are carried forward without complete isolation, maintaining useful action throughout the synthesis. This continuity significantly increases the quantity of product that can be produced from given starting materials, directly addressing the contradiction between quantity produced and synthetic efficiency.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Facilitates the synthesis of large quantities of LXB4 for studying neuronal signaling mechanisms and evaluating therapeutic potential, providing unambiguous structural confirmation and enabling the development of analogues for neuroprotection.
Implementation Method 1
performing a selective semi-hydrogenation of the triple bond in the compound of Formula Va to form the compound of Formula I
Data Source
AI summary
The present application provides a synthetic process for production of lipoxin B4 and analogues thereof, which is modular and scalable, thus permitting synthesis of large quantities of LXB4 and analogues thereof, including radiolabeled analogues. Also provided are intermediate compounds that are useful in the synthetic process for production of lipoxin B4 and analogues thereof.